SHARE MARKET

2 FTSE 100 dividend stock that I would never want to sell


I will not try to keep my every investment forever. But at least there is something FTSE 100 Dividend stock was the goal I never sold.

Growth by R&D pipeline

E.g., pharmaceutical companies Astrageneca (LSE: AZN) strikes me as a top quality business operating in an attractive sector. And at the end of July, the company said in its interim results report that it “Accelerate top-line growth with continued pipeline progress ”.

A killer stock for cyber security surge

Cyber ​​security is on the rise, experts predict The cyber security market will reach 366 billion US dollars by 2028More than double what we have today!

And with this kind of growth, this North American company stands as the biggest winner.

Because their patented “self-repair” technology is changing the landscape of cyber security as we know it …

We think this is likely to be the next famous technology success story. In fact, we think it could be so big … or even Bigger than Shopify.

Click here to see how you can unveil the name of this North American stock that occupies Silicon Valley, one device at a time …

Indeed, the Research and Development (R&D) pipeline has offered a lot of potential over the years. But lately the firm’s Regulatory News Service (RNS) feed has come alive with positive announcements.

AstraZeneca believes the pipeline is releasing new money-making treatments and drugs “Based on transformation into long-term sustainable growth” And there is a high-example of business affordability recently when it made its Covid-1 vaccine and gave it to the world at a price.

Meanwhile, with the share price hovering around 8,635p, the future dividend yield for 2022 is about 2.4%. It does not have the highest FTSE 100 yield available. But I think the business is capable of driving into the years ahead. But, of course, like all companies and stocks, there are risks and chances of success in the future. Nonetheless, I would like to focus on the quality of the enterprise and aim to hold on to some stocks that will become thicker and thinner in the future.

FTSE 100 is a great sector to bear dividend stock

And along with AstraZeneca I want to target Unilever (LSE: ULVR), a fast-moving consumer goods giant.

I think the branded consumer goods sector is a suitable place to look for sustainable investment. Theoretically, companies operating in this sector create a steady cash flow of what the economy is doing. And I think it happens because people like to buy their favorite food, clean and other staples, no matter how difficult things are for them financially.

And Unilever is the sector’s London-listed behemoth. It has a long record of trading and financial success, as driven by its good brand CIF, Domestos, Hellman, Marmite And much more.

In a report on the July interim results, chief executive Alan Jopp said the company was making “Good Improvement” In product portfolio development “High growth space”. Of course, nothing is certain, but I expect Unilever to increase its shareholder dividends and its earnings by a modest, single-digit percentage each year. And if that doesn’t happen, and even if the share price goes down and I lose money on paper, I’ll probably hold on to my stock.

Now, with the share price hovering around 3,809p, the expected dividend yield for 2022 is about 3.3%. Again, this is not the highest yield of the FTSE 100. .

I am not guaranteeing positive investment results because I prefer these two stocks now. Things can go wrong in both underlying trades – all stocks carry risk. But these are two FTSE 100 dividend stocks that I will never sell.

I’m hunting here too:

5 stocks to try to make wealth after 50

Coronavirus epidemic disrupts markets around the world …

And many big companies that are trading at ‘discount-bin’ prices may now be able to bargain for potential investors.

But whether you are a novice investor or an experienced professional, deciding which stock to add to your shopping list can be a risky prospect at such an unprecedented time.

Fortunately, The Motley Flower is here to help: We have five companies shortlisted by the UK’s chief investment officer and his analyst team that they believe have the potential for long-term growth despite a global lockdown.

You see, here in The Motley Flower we don’t believe that “over-trading” is the right path to financial freedom in retirement; Instead, we are in favor of purchasing and holding (for at least three to five years) 15 or more quality companies, led by a shareholder-centric management team.

That’s why we’re sharing the names of these five companies in a special investment report that you can download for free today. If you are 50 or older, we believe these stocks can be suitable for any diversified portfolio, and you can create a position in the top five right now.

Click here to claim a free copy of this special investment report!


Kevin Godbold has no position in any of the shares mentioned. Motley Flower UK has recommended Unilever. Opinions expressed in the companies mentioned in this article may differ from those of the author and therefore our official recommendations in our subscription services such as Share Advisors, Hidden Winners and Pro. Here at The Motley Flower we believe that considering a variety of insights makes us a better investor.





Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button